Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Karyopharm Therapeutics at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Karyopharm Therapeutics exhibits at Booth 939 at ASH 2026 in New Orleans. Karyopharm Therapeutics supports a symposium on myelofibrosis. Using patient cases, it looks at where treatment stands today and where it is going next.

OrganizationASH 2026 Attendance
karyopharm.com
Biotech
Commercial-stage cancer drug company whose SINE compounds block the nuclear export protein XPO1, with a focus on blood cancers.
Booth
Exhibiting at Booth 939
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
3:00pm–6:00pm
A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going
Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies.
Sheraton New Orleans · Napoleon Ballroom CD
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Karyopharm Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction